Sale!

CDHR1 Gene Cone-Rod Dystrophy Type 15 NGS Genetic DNA Test

Original price was: R9,350.Current price is: R6,700.

-28%

Facing concerns about inherited vision loss? Our CDHR1 Cone-Rod Dystrophy Type 15 NGS Genetic DNA Test provides definitive answers about your genetic risk for this progressive eye condition. For only ZAR 6,700 (regularly ZAR 9,350), you’ll receive comprehensive testing using advanced NGS technology that delivers 99.9% accuracy. This test specifically identifies mutations in the CDHR1 gene that cause cone-rod dystrophy, helping you understand your family’s genetic inheritance pattern. With professional genetic counselling included, you’ll receive personalised guidance about your results and what they mean for your vision health. Early detection through genetic testing can help preserve your remaining vision and guide appropriate management strategies. Available nationwide with convenient testing locations in Johannesburg, Cape Town, Durban, and Pretoria.

📞 24/7 South African Support Team Call : +27 6412 56421

  • ✓ ISO Accredited Lab Reports
  • ✓ Free Genetic Counseling Included
  • 🔒 100% Confidential & Secure Testing
Guaranteed Safe Checkout

CDHR1 Cone-Rod Dystrophy DNA Test | ZAR 6
CDHR1 Gene Cone-Rod Dystrophy Type 15 NGS Genetic DNA Test
R9,350 Original price was: R9,350.R6,700Current price is: R6,700.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Take Control of Your Vision Health with CDHR1 Cone-Rod Dystrophy Genetic Testing

If you’re worried about inherited vision problems or have family members with cone-rod dystrophy, you’re not alone. Many South Africans face the uncertainty of genetic eye conditions that can affect their quality of life. Our CDHR1 Cone-Rod Dystrophy Type 15 NGS Genetic DNA Test provides the clarity and answers you need to make informed decisions about your eye health and future.

Understanding Your CDHR1 Genetic Test

This advanced genetic test specifically examines the CDHR1 gene using Next-Generation Sequencing (NGS) technology, which is the gold standard for genetic testing accuracy. The CDHR1 gene plays a crucial role in maintaining healthy retinal function, and mutations in this gene can lead to cone-rod dystrophy type 15 – a progressive condition that affects both central and peripheral vision.

Unlike standard eye exams that detect existing vision problems, this genetic test can identify your risk before significant symptoms develop, giving you the power to take proactive steps to preserve your vision.

Who Should Consider This Genetic Test?

This test is particularly important if you experience:

  • Progressive vision loss starting in childhood or early adulthood
  • Difficulty with colour vision or night blindness
  • Family history of inherited retinal diseases
  • Diagnosis of cone-rod dystrophy in relatives
  • Planning for pregnancy and concerned about genetic inheritance
  • Unexplained vision changes despite normal eye exams

If any of these situations resonate with you, genetic testing can provide the answers you’ve been seeking.

Why Early Detection Matters for Your Vision Health

Getting tested for CDHR1 cone-rod dystrophy offers life-changing benefits:

  • Peace of Mind: Eliminate the uncertainty about your genetic risk and inheritance pattern
  • Early Intervention: Begin appropriate monitoring and management strategies before significant vision loss occurs
  • Family Planning: Make informed decisions about having children and understanding inheritance risks
  • Personalised Care: Work with your ophthalmologist to create a vision preservation plan tailored to your genetic profile
  • Clinical Trial Access: Qualify for emerging treatments and research studies for genetic eye conditions

Understanding Your Test Results

We understand that waiting for genetic test results can be anxiety-provoking. That’s why we include comprehensive genetic counselling with every test. Our certified genetic counsellors will:

  • Explain your results in clear, understandable language
  • Discuss what the findings mean for your vision health
  • Help you understand inheritance patterns and family implications
  • Connect you with appropriate ophthalmology specialists
  • Provide emotional support and guidance throughout the process

Whether your results show a genetic mutation or provide reassuring information, you’ll have the professional support you need to move forward confidently.

Affordable Genetic Testing with Exceptional Value

Service Regular Price Special Price Savings
CDHR1 Cone-Rod Dystrophy NGS Test ZAR 9,350 ZAR 6,700 ZAR 2,650
Professional Genetic Counselling INCLUDED at no extra cost
Family Pedigree Analysis INCLUDED with your test

Test Details:

  • Turnaround Time: 3-4 weeks
  • Sample Type: Blood, Extracted DNA, or One drop Blood on FTA Card
  • Preparation: Clinical history and genetic counselling session required
  • Technology: NGS (Next-Generation Sequencing) – 99.9% accuracy

Why Trust Oracle Genomics with Your Genetic Testing?

We understand that genetic testing is a deeply personal decision. That’s why we’ve built our reputation on:

  • Medical Expertise: Working exclusively with certified ophthalmologists and genetic specialists
  • Nationwide Coverage: Convenient testing locations in Johannesburg, Cape Town, Durban, Pretoria and throughout South Africa
  • Accuracy Guarantee: Using only the most advanced NGS technology for reliable results
  • Patient Privacy: Strict confidentiality and ethical handling of your genetic information
  • Comprehensive Support: From initial consultation through results explanation and beyond

Take the First Step Toward Vision Health Clarity

Don’t let uncertainty about your genetic vision health hold you back. With our special pricing of only ZAR 6,700, there’s never been a better time to get the answers you deserve.

Limited Time Offer: This special pricing of ZAR 6,700 (regularly ZAR 9,350) won’t last forever. Secure your genetic testing today and take control of your vision health journey.

“The clarity from genetic testing gave our family the power to plan for the future with confidence.” – Recent Oracle Genomics Patient